India has suspended a drugmaker’s manufacturing licence after the World Health Organization flagged contamination in its cough syrups found in the Mashall Islands and Micronesia in April, the government told the parliament on Tuesday. Indian regulators are inspecting drugmakers after cough syrups made in the country were linked to at least 89 child deaths in Gambia and Uzbekistan last year, which has damaged India’s image as the “pharmacy of the world” providing affordable drugs globally.
Recent Posts
- Binance’s $6.3 Billion Hack: How Crypto insurance works
- Create a culture of addressing policyholder grievances proactively, Seth urges insurers
- Nat Cat claims pull GIC Re’s net profit down 14% to Rs 2456 cr in Q2FY27, Prm rises 17% to Rs 11,228 crore
- New India focuses on underwriting, technology for profitable growth: CMD
- Govt sets up high-level banking reform panel headed by former CVC Suresh N Patel
Categories
- Articles
- Banking & Bancassurance
- Blog
- Breaking News!
- Briefs
- Climate, Environment, Renewable Energy
- Data
- Disaster & Management
- Eco/Invest/Demography
- Editorial
- Events
- Facts
- Features
- Health
- Indian News
- Intermediaries
- International News
- Interviews
- Life
- Main Menu
- Non-Life
- Pandemic
- Pension & Social Security
- Policy
- Regulation
- Reinsurance
- Risk Management
- Simple
- Technology
- Trends, Facts
- Uncategorized
- Wealth Management/ Philanthropy
- Workplace/Employee Benefits